Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Imaging synaptic microstructure and synaptic loss in vivo in early Alzheimer’s Disease

Ashwin V Venkataraman, Courtney Bishop, Ayla Mansur, Gaia Rizzo, Yvonne Lewis, Ece Kocagoncu, Anne Lingford-Hughes, Mickael Huiban, Jan Passchier, James B Rowe, Hideo Tsukada, David J. Brooks, Laurent Martarello, Robert A. Comley, Laigao Chen, Richard Hargreaves, Adam J. Schwarz, Roger N. Gunn, Eugenii A. Rabiner, View ORCID ProfilePaul M Matthews
doi: https://doi.org/10.1101/2021.11.23.21266746
Ashwin V Venkataraman
1Department of Brain Sciences, Imperial College London; London, UK
2UK Dementia Research Institute at Imperial College London; London, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Courtney Bishop
3Invicro LLC.; London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayla Mansur
3Invicro LLC.; London, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaia Rizzo
1Department of Brain Sciences, Imperial College London; London, UK
3Invicro LLC.; London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvonne Lewis
3Invicro LLC.; London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ece Kocagoncu
5University of Cambridge; Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Lingford-Hughes
1Department of Brain Sciences, Imperial College London; London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mickael Huiban
3Invicro LLC.; London, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Passchier
3Invicro LLC.; London, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James B Rowe
5University of Cambridge; Cambridge, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideo Tsukada
6Hamamatsu Photonics; Hamamatsu,Japan
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Brooks
7University of Newcastle upon Tyne, UK and Aarhus University; DK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Martarello
8Biogen, Cambridge; USA
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Comley
9AbbVie, Chicago; USA
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laigao Chen
10Pfizer Inc., Cambridge; USA
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Hargreaves
11Bristol Myers Squibb; New York, USA
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J. Schwarz
12Takeda Pharmaceuticals Ltd; Cambridge, USA
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger N. Gunn
1Department of Brain Sciences, Imperial College London; London, UK
3Invicro LLC.; London, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugenii A. Rabiner
3Invicro LLC.; London, UK
4King’s College London; London, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul M Matthews
1Department of Brain Sciences, Imperial College London; London, UK
2UK Dementia Research Institute at Imperial College London; London, UK
13MINDMAPS Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul M Matthews
  • For correspondence: p.matthews@imperial.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

1. ABSTRACT

Background Synaptic loss and neurite dystrophy are early events in Alzheimer’s Disease (AD). We aimed to characterise early synaptic microstructural changes in vivo.

Methods MRI neurite orientation dispersion and density imaging (NODDI) and diffusion tensor imaging (DTI) were used to image cortical microstructure in both sporadic, late onset, amyloid PET positive AD patients and healthy controls (total n = 28). We derived NODDI measures of grey matter extracellular free water (FISO), neurite density (NDI) and orientation dispersion (ODI), which provides an index of neurite branching and orientation, as well as more conventional DTI measures of fractional anisotropy (FA), mean/axial/radial diffusivity (MD, AD, RD, respectively). We also performed [11C]UCB-J PET, which provides a specific measure of the density of pre-synaptic vesicular protein SV2A. Both sets of measures were compared to regional brain volumes.

Results The AD patients showed expected relative decreases in regional brain volumes (range, -6 to - 23%) and regional [11C]UCB-J densities (range, -2 to -25%). Differences between AD and controls were greatest in the hippocampus. NODDI microstructural measures showed greater FISO (range, +26 to +44%) in AD, with little difference in NDI (range, -1 to +7%) and mild focal changes in ODI (range, -4 to +3%). Regionally greater FISO and lower [11C]UCB-J binding were correlated across grey matter in patients (most strongly in the caudate, r2 = 0.37, p = 0.001). FISO and DTI RD were strongly positively associated, particularly in the hippocampus (r2 = 0.98, p < 7.4 × 10−9). After 12-18 months we found a 5% increase in FISO in the temporal lobe, but little change across all ROIs in NDI and ODI. An exploratory analysis showed higher parietal lobe FISO was associated with lower language scores in people with AD.

Conclusions We interpreted the increased extracellular free water as a possible consequence of glial activation. The dynamic range of disease-associated differences and the feasibility of measuring FISO on commercially available imaging systems makes it a potential surrogate for pathology related to synapse loss that could be used to support early-stage evaluations of novel therapeutics for AD.

Competing Interest Statement

AVV and ALH declare that they have no competing interests. PMM acknowledges consultancy fees from Novartis, Bristol Myers Squibb, Celgene and Biogen He has received honoraria or speakers honoraria from Novartis, Biogen and Roche and has received research or educational funds from Biogen, Novartis, GlaxoSmithKline and Nodthera. CB, AM, GR, YL, MH, JP, RNG, EAR are employees of Invicro, a Konica Minolta Company. JBR serves as Editor to Brain; Chief Scientific Advisor to ARUK; and have consultancies with UCB, Asceneuron, Biogen, WAVE, SV Health, Astex unrelated to the current work; and have research grants from Janssen, Lilly, AstraZeneca. LM is an employee of Biogen. RC is an employee and shareholder of AbbVie, Inc. LC is an employee and shareholder of Pfizer, Inc. AJS is a full-time employee and shareholder of Takeda Pharmaceuticals, Ltd. HT is an employee of Hamamatsu Photonics. RH is a full-time employee and shareholder of Bristol Myers Squibb.

Funding Statement

Alzheimers Society, grant number 440, AS-CTF-18-006 (AVV), NIHR Biomedical Research Centre, Imperial College London (AVV, PMM), UK Dementia Research Institute (supported by the UKRI Medical Research Council, Alzheimers Society and Alzheimers Research UK) (PMM), NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) (JBR), Medical Research Council (SUAG/051 G101400; MR/L023784/2; MR/N029941/1) (JBR)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants provided written informed consent. Ethical approval for this study was provided by the NHS London - Brighton & Sussex Research Ethics Committee (REC 18/LO/0179) for AD patients and East of England Cambridge Central & South Research Ethics Committee for controls. Radiation safety was approved by the Administration of Radioactive Substances Advisory Committee (ARSAC R92), London. Local site approval was provided by Imperial College London Joint Research Office.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Author email addresses:

    Ashwin V Venkataraman a.venkataraman{at}imperial.ac.uk

    Courtney Bishop Courtney.Bishop{at}invicro.co.uk

    Ayla Mansur Ayla.Mansur{at}invicro.co.uk

    Gaia Rizzo Gaia.Rizzo{at}invicro.co.uk

    Yvonne Lewis yvonne.lewis1{at}invicro.co.uk

    Ece Kocagoncu ek390{at}cam.ac.uk

    Anne Lingford-Hughes anne.lingford-hughes{at}imperial.ac.uk

    Mickael Huiban Mickael.Huiban{at}invicro.co.uk

    Jan Passchier Jan.Passchier{at}invicro.co.uk

    James B Rowe james.rowe{at}mrc-cbu.cam.ac.uk

    Hideo Tsukada tsukada0412{at}nifty.com

    David J. Brooks david.brooks{at}newcastle.ac.uk

    Laurent Martarello laurent.martarello{at}biogen.com

    Robert A. Comley robert.comley{at}abbvie.com

    Laigao Chen laigao.chen{at}pfizer.com

    Richard Hargreaves Richard.Hargreaves{at}bms.com

    Adam J. Schwarz Adam.Schwarz{at}takeda.com

    Roger N. Gunn Roger.Gunn{at}invicro.co.uk

    Eugenii A. Rabiner Ilan.Rabiner{at}invicro.co.uk

    Paul M Matthews p.matthews{at}imperial.ac.uk

Data Availability

Non-identifible data produced in the present study are available upon reasonable request to the authors

  • List of abbreviations

    [11C]
    11-Carbon
    [18F]
    18-Fluorine
    1TC
    One-Tissue Compartment
    2TC
    Two-Tissue Compartment
    ACE III
    Addenbrooke’s Cognitive Examination III
    AD
    Alzheimer’s Disease
    AD
    Axial Diffusivity
    Aβ
    Amyloid-β
    CN
    Cognitively Normal
    CS
    Centrum semiovale
    DTI
    Diffusion tensor imaging
    DVR
    Distribution volume ratio
    ER
    Endoplasmic Reticulum
    ETC
    Electron Transport Chain
    FA
    Fractional anisotropy
    FISO
    Fraction of isotropic
    GM
    Grey matter
    MBq
    Megabecquerel
    MCI
    Mild cognitive impairment
    MD
    Mean diffusivity
    MMSE
    Mini mental state examination
    MNI
    Montreal Neurological Institute
    MRI
    Magnetic Resonance Imaging
    ms
    Millisecond
    mSv
    Millisievert
    NART
    National Adult Reading Test
    NDI
    Neurite Density Index
    NIA-AA
    National Institute on Aging and Alzheimer’s Association
    NODDI
    Neurite Orientation Density and Dispersion Imaging
    ODI
    Orientation dispersion index
    PET
    Positron Emission Tomography
    PVC
    Partial Volume Correction
    RD
    Radial Diffusivity
    ROI
    Region of Interest
    SPM12
    Statistical Parametric Mapping version 12
    SUVr
    Standardised Uptake Value ratio
    SV2A
    Synaptic Vesicle Protein 2A
    UCB-J
    ((R)-1-((3-((11)C-methyl-(11)C)pyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl) pyrrolidin-2-one)
    WM
    White matter
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted November 24, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Imaging synaptic microstructure and synaptic loss in vivo in early Alzheimer’s Disease
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Imaging synaptic microstructure and synaptic loss in vivo in early Alzheimer’s Disease
    Ashwin V Venkataraman, Courtney Bishop, Ayla Mansur, Gaia Rizzo, Yvonne Lewis, Ece Kocagoncu, Anne Lingford-Hughes, Mickael Huiban, Jan Passchier, James B Rowe, Hideo Tsukada, David J. Brooks, Laurent Martarello, Robert A. Comley, Laigao Chen, Richard Hargreaves, Adam J. Schwarz, Roger N. Gunn, Eugenii A. Rabiner, Paul M Matthews
    medRxiv 2021.11.23.21266746; doi: https://doi.org/10.1101/2021.11.23.21266746
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Imaging synaptic microstructure and synaptic loss in vivo in early Alzheimer’s Disease
    Ashwin V Venkataraman, Courtney Bishop, Ayla Mansur, Gaia Rizzo, Yvonne Lewis, Ece Kocagoncu, Anne Lingford-Hughes, Mickael Huiban, Jan Passchier, James B Rowe, Hideo Tsukada, David J. Brooks, Laurent Martarello, Robert A. Comley, Laigao Chen, Richard Hargreaves, Adam J. Schwarz, Roger N. Gunn, Eugenii A. Rabiner, Paul M Matthews
    medRxiv 2021.11.23.21266746; doi: https://doi.org/10.1101/2021.11.23.21266746

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (243)
    • Allergy and Immunology (524)
    • Anesthesia (125)
    • Cardiovascular Medicine (1432)
    • Dentistry and Oral Medicine (219)
    • Dermatology (158)
    • Emergency Medicine (292)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
    • Epidemiology (10326)
    • Forensic Medicine (6)
    • Gastroenterology (533)
    • Genetic and Genomic Medicine (2652)
    • Geriatric Medicine (255)
    • Health Economics (499)
    • Health Informatics (1744)
    • Health Policy (791)
    • Health Systems and Quality Improvement (680)
    • Hematology (269)
    • HIV/AIDS (570)
    • Infectious Diseases (except HIV/AIDS) (12116)
    • Intensive Care and Critical Care Medicine (650)
    • Medical Education (274)
    • Medical Ethics (83)
    • Nephrology (291)
    • Neurology (2478)
    • Nursing (145)
    • Nutrition (381)
    • Obstetrics and Gynecology (496)
    • Occupational and Environmental Health (569)
    • Oncology (1332)
    • Ophthalmology (403)
    • Orthopedics (151)
    • Otolaryngology (239)
    • Pain Medicine (172)
    • Palliative Medicine (51)
    • Pathology (344)
    • Pediatrics (785)
    • Pharmacology and Therapeutics (334)
    • Primary Care Research (296)
    • Psychiatry and Clinical Psychology (2417)
    • Public and Global Health (5029)
    • Radiology and Imaging (900)
    • Rehabilitation Medicine and Physical Therapy (533)
    • Respiratory Medicine (687)
    • Rheumatology (309)
    • Sexual and Reproductive Health (257)
    • Sports Medicine (246)
    • Surgery (300)
    • Toxicology (45)
    • Transplantation (141)
    • Urology (108)